The Global Humira Biosimilar Market Is Estimated To Be Valued At US$ 772.1 Million In 2023 And Is Expected To Exhibit A CAGR Of 25.9%

sachin sadgir

The Global Humira Biosimilar Market Is Estimated To Be Valued At US$ 772.1 Million In 2023 And Is Expected To Exhibit A CAGR Of 25.9%

Market Overview:

Humira(adalimumab) is a human monoclonal antibody used to treat various autoimmune diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis and psoriasis. Biosimilar versions provide cost effective treatment options with comparable safety and efficacy.

Market key trends:

One of the key trends in the humira biosimilar market is the patent expiration of Humira's reference product. AbbVie's patent on Humira expired in major markets like Europe in October 2018 and will expire in the US in December 2023, allowing for biosimilar competition. This has led to several biosimilar approvals and launches by companies like Amgen, Sandoz and Boehringer Ingelheim. Increased biosimilar penetration is expected to substantially reduce treatment costs and expand patient access to biologic therapy for various chronic conditions.

Segment Analysis

The global Humira Biosimilar Market biosimilar market is dominated by the rhematoid arthritis sub-segment. Currently, Humira is approved for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis and uveitis. The rheumatoid arthritis sub-segment holds the largest market share as rheumatoid arthritis is the most common chronic inflammatory condition affecting approximately 1% of the adult population globally. Humira has been approved for the treatment of moderate to severe active rheumatoid arthritis.

Key Takeaways

The global Humira biosimilar market is expected to witness high growth, exhibiting CAGR of 25.9% over the forecast period 2023 - 2030, due to increasing prevalence of immune-mediated inflammatory diseases globally.

Regional analysis

The US region currently dominates the global Humira biosimilar market with a share of over 60% in 2023. However, the Asia Pacific region is expected to emerge as the fastest growing market during the forecast period. Countries like China, India, South Korea and Japan are expected to offer lucrative opportunities for market players due to rising healthcare spending and increasing generic penetration in the region.

Key players

Key players operating in the Humira biosimilar market are Amgen Inc., Samsung Bioepis Co., Ltd., Sandoz International GmbH (Novartis AG), Mylan N.V., Boehringer Ingelheim International GmbH, Pfizer Inc., Fresenius Kabi AG, Coherus BioSciences, Inc., Biogen Inc., AbbVie Inc., Celltrion Inc., Amneal Pharmaceuticals, Inc., Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Viatris Inc. Amgen Inc. generated the highest revenue from Humira biosimilars in 2023.

sachin sadgir

Pooja Khodke 2024-01-29

As patent exclusivity of Humira is expiring in major markets by 2023, several pharmaceutical companies are investing in developing Humira biosimilars. The global Humira Biosimilar Market is estimated to be valued at US$ 889. This is expected to boost the humira biosimilars market growth during the forecast period. Key TakeawaysThe Global Humira Biosimilar Market Demand is expected to witness high growth during the forecast period of 2024 to 2031. Key players operating in the Humira biosimilar market are NestlÃ© S.

The Global Humira Biosimilar Market is driven by rising healthcare costs

naufan 2024-02-26

The global Humira biosimilar market consists of biosimilar drugs to treat autoimmune diseases and other chronic conditions. The global Humira biosimilar market is estimated to be valued at US$ 889. Key Takeaways Key players operating in The Humira Biosimilar Market are NestlÃ© S. Geopolitical Situation and Market Growth The current geopolitical turbulence and tensions between major economies is impacting the Humira biosimilar market growth. Fastest Growing Regional Market Asia Pacific region holds the maximum growth potential for Humira biosimilar market during the forecast period from 2024 to 2030.

Ben Wood 2023-09-28

The increasing prevalence of autoimmune diseases, rising demand for cost-effective treatments, and patent expirations of key biologic drugs are driving the growth of the Humira biosimilar market. As a result, the Humira biosimilar market is witnessing significant growth and is expected to continue to expand in the coming years. Based on product type, the dominant segment in the Humira biosimilar market is the adalimumab segment, which is expected to hold the largest market share. In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the Humira biosimilar market. These key players play a significant role in driving market growth through their product developments, strategic collaborations, and mergers and acquisitions.

Let’s Understand the rise of Humira Biosimilar

Lucy Kart 2024-03-12

Major Humira biosimilars approved Since Humira's patent expired in late 2022, many companies rushed to develop biosimilars. Impact on market and costs Analysts predict Humira biosimilars could capture over 60% of the US market by 2024. For example, Medicare is predicted to save $5 billion by 2026 just through increased Humira biosimilar utilization. If more Humira biosimilars gain interchangeable status, it could potentially accelerate uptake further. Get More Insights on Humira Biosimilar

Humira Drug Market 2023 | Market Size, Industry Trends, Share, Market Analysis, Key Drivers, Top Major Players And Forecast To 2032

sai tbrc 2023-09-04

The Humira Drug Global Market Report 2023, provides comprehensive information on the humira drug market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The size of humira drug market is expected to reach $12. id=11934&type=smp The Humira Drug market is segmented:1) By Type: Humira Syringe, Humira Pen2) By Application: Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn's Disease, Other Applications3) By End-Users: Hospitals, Specialty Clinics, Other End-Users North America was the largest region in the Humira Drug market in 2022. Key Mergers And Acquisitions In The Humira Drug Market35. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

imarc 2023-04-20

According to the recent report by IMARC Group, entitled “Biosimilar Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2023-2028”, the global biosimilar market size reached US$ 16. To be labeled as a biosimilar, a biological drug must be proved similar in terms of efficacy, safety, and quality. com/biosimilar-market/requestsample Biosimilar Market Trends:The surging prevalence of chronic diseases, such as cancer and autoimmune diseases, especially among the geriatric population, represents one of the key factors significantly contributing to the market growth. type=report&id=497&flag=CKey Highlights of the Report: Market Performance (2017-2022)Market Outlook (2023-2028)Market TrendsMarket Drivers and Success FactorsImpact of COVID-19Value Chain AnalysisComprehensive mapping of the competitive landscapeIf you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization. About Us IMARC Group is a leading market research company that offers management strategy and market research worldwide.

WHO TO FOLLOW

MORE FROM AUTHOR

Commercial Or Corporate Card Market to Reach US$26.3 Billion by 2022, with a CAGR of 7.3%

sachin sadgir 2023-10-30

Textiles and Apparel Market Outlook in the Coming Decade

sachin sadgir 2023-10-30

Septic Solutions Market Contribution: Treatment For Waste Water Management

sachin sadgir 2023-10-30

The Global Tumor Treating Fields Market Is Estimated To Be Valued At US$333.8 Million In 2023 And Is Expected To Exhibit A CAGR Of 15.5%

sachin sadgir 2023-10-30

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Aishwarya Bhasme 2023-08-02

The research provides an overview of the worldwide Biosimilar market, including market characteristics, market segmentation analysis, market size, customer landscape, and geographical landscape. com/request-sample/83592 Biosimilar Market Key Players:It then discusses the top competitors in the worldwide Biosimilar market, as well as emerging players, in detail, including market share based on revenue, demand, high-quality product makers, sales, and service providers. Key Questions Answered in the Biosimilar Market Report are: Which are the major companies in the Biosimilar market? Which region holds the largest market share in the Biosimilar market? What factors are anticipated to drive the Biosimilar market?

Ruchita 2022-01-28

The global Biosimilar Insulin Market report offers a comprehensive assessment of the market for the forecast years. com/contact/download-sample-47261The Global Biosimilar Insulin Market Report is equipped with market data from 2016 to 2026. COVID-19 Impact Analysis on Biosimilar Insulin MarketThe global pandemic COVID-19 has affected the Biosimilar Insulin market directly or indirectly. Chapter 2: To profile the top manufacturers of Biosimilar Insulin, with price, sales, revenue, and global market share of Biosimilar Insulin in 2018 and 2019. Directly Purchase the Complete Global Biosimilar Insulin Market Research Report @ https://www.

Humira Market Size, Share, Future Industry Projections & Forecast Report 2020-2025

Joshna Cristila 2020-04-18

The statistical surveying report on the global Humira Market has been presented by using professional or expert knowledge through standard and modified research approaches and forecasts.

The yearly forecast and predication for the years 2020 to 2025 have been enclosed by the report along with comprehensive analysis for all market segments and regions.

The statistical data derived from authentic resources and assisted by industry experts.

It likewise assesses the market by evaluating market elements, including drivers, restraints, opportunities, threats, challenges, growth prospects, and other market elements.

The global Humira market report presents a complete research-based study of the industry including details such as company shares, forecast data, in-depth analysis and an outlook of the market on a worldwide platform.

Get FREE Sample Report Copy @ https://www.decisiondatabases.com/contact/download-sample-46179 According to this study, over the next five years, the Humira market will register a -13.0% CAGR in terms of revenue, the global market size will reach $ 6762.1 million by 2025, from $ 11790 million in 2019.

Ganesh Shinde 2023-02-03

During the forecast period, the remicade biosimilar market is expected to develop at a CAGR of 35. The value of the remicade biosimilar market is expected to reach US$ 47,549. By Disease Indication:Crohn’s diseaseRheumatoid arthritisAnkylosing spondylitisPsoriatic arthritisUlcerative ColitisPlaque psoriasisRemicade Biosimilar Market: Competition AnalysisThe FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Remicade Biosimilar market. Competitive information detailed in the Remicade Biosimilar market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Remicade Biosimilar market report.

saikiran TBRC 2024-03-02

Learn More On The Remicade Biosimilar Market:https://www. The remicade biosimilar market size is expected to see exponential growth in the next few years. Major trends in the forecast period include physician prescribing behavior, biosimilar lifecycle management, biosimilar naming conventions, biosimilar interchangeability, biosimilar real-world evidence. The rise in the incidence of autoimmune diseases is expected to propel the growth of the remicade biosimilar market going forward. Major companies operating in the Remicade biosimilar market are developing innovative products to sustain their position in the market.

Aafiya.Khanam 2021-11-17

The newly added Remicade Biosimilar Market research report by Value Market Research disclose all the important information associated with the market such as value, growth factor, trends, market share, size, and challenges for the forecasted timeline 2020-2027. The report also covers detailed competitive landscape including company profiles of key players operating in the global market. Get more information on "Global Remicade Biosimilar Market Research Report" by requesting FREE Sample Copy athttps://www. Browse Global RemicadeBiosimilar Market Research Report with detailed TOC athttps://www. By Disease Indication· Ulcerative Colitis· Rheumatoid Arthritis· Ankylosing Spondylitis· Crohn’s Disease· Psoriatic Arthritis· Plaque PsoriasisRegional AnalysisFurthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for remicadebiosimilar in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

kashish Singh 2023-04-12

Get more information on "Global Biosimilar Monoclonal Antibody Market Research Report" by requesting FREE Sample Copy at https://www. com/contact/biosimilar-monoclonal-antibody-market/download-sampleMarket DynamicsThe reason for the biosimilar monoclonal antibody market growth is the rising prevalence of chronic diseases worldwide. Rising generic population and increasing cases of diseases like rheumatoid arthritis and cancers are contributing to the biosimilar monoclonal antibody market growth. Additionally, these tools also give an inclusive assessment of each segment in the global market of biosimilar monoclonal antibody. Purchase Complete Global Biosimilar Monoclonal Antibody Market Research Report at https://www.

Devanand Patil 2021-10-13

Herceptin Biosimilar Market: IntroductionTrastuzumab, sold under the brand Herceptin, is a monoclonal antibody used to treat patients suffering from HER2+ve breast cancer and gastric cancers.

It is primarily administered intravenously in cancer patients.

Herceptin binds to HER2 receptors on the surface of breast cancer cells and blocks them from receiving growth signals, thereby leading to apoptosis and decrease in mutation of cells.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=82800 Key Drivers and Restraints of Global Herceptin Biosimilar MarketBreast cancer is one of the leading causes of death among women across the globe.

Increase in incidence and prevalence of gastric & breast cancer among people, especially women, is a key factor boosting the growth of the global Herceptin biosimilar market.

According to a report by the World Health Organization in 2019, nearly 627,000 women across the globe succumbed to breast cancer, which accounted for around 15% of all cancer deaths among women, in 2018.New product launches along with a number of products in pipeline for clinical trials, approval of new Herceptin biosimilar drugs by key companies, technological advancements, increase in health care expenditure, and considerable research & development activities drive the global Herceptin biosimilar market.However, lack of awareness among people about the treatment of gastric & breast cancer with Herceptin is likely to hamper the growth of the global Herceptin biosimilar market in the next few yearsRequest COVID Analysis on Herceptin Biosimilar Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=82800 Breast Cancer to Dominate Global Herceptin Biosimilar MarketIn terms of indication, the global Herceptin biosimilar market can be classified into breast cancer, gastric cancer, and othersThe breast cancer segment is projected to dominate the global Herceptin biosimilar market during the forecast period due to increase in incidence and prevalence rate of breast cancer among womenHospital Pharmacy Segment to Capture Largest Market ShareBased on distribution channel, the global Herceptin biosimilar market can be divided into hospital pharmacies, retail pharmacies, online pharmacies, oncology centers, and othersThe hospital pharmacies segment is anticipated to capture the largest market share due to rise in the number of patients admitted to hospitals & clinics for treatment and health care infrastructure provided by hospitals such as intensive care units (ICU) and ventilators.North America to Lead Global Herceptin Biosimilar MarketIn terms of region, the global Herceptin biosimilar market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & AfricaNorth America accounted for the largest market of the global Herceptin biosimilar market in 2020, followed by Europe.

Increase in number of people suffering from gastric & breast cancer, technological advancements, rise in government grants & funding, and presence of large number of key players boost the growth of the market in North America.Pre Book Herceptin Biosimilar Market Report- https://www.transparencymarketresearch.com/checkout.php?rep_id=82800=S Key Manufacturers Operating in Global Herceptin Biosimilar MarketThe global Herceptin biosimilar market was highly fragmented in 2020.

Biswadeep 2022-05-23

The Biosimilar Interleukins Global Market Report 2021-31 by The Business Research Company describes and explains the global biosimilar interleukins market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region. The biosimilar interleukins market share is expected to reach $7. id=3433&type=smp Biosimilar Interleukins Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.

Santhosh 2022-05-20

The Biosimilar Lymphocyte Modulator Global Market Report 2022 covers biosimilar lymphocyte modulator market drivers, biosimilar lymphocyte modulator market trends, biosimilar lymphocyte modulator market segments, biosimilar lymphocyte modulatormarket growth rate, biosimilar lymphocyte modulatormarket major players, and biosimilar lymphocyte modulatormarket size. The global biosimilar lymphocyte modulator market size is expected to grow from $1. The biosimilar lymphocyte modulator market share is expected to reach $2. Key Mergers And Acquisitions In The Biosimilar Lymphocyte Modulator Market30. AppendixAbout The Business Research Company: The Business Research Company is a market intelligence firm that excels in company, market, and consumer research.

Ramya 2022-05-25

The Biosimilar Hormones Global Market Report 2021-31 by The Business Research Company describes and explains the global biosimilar hormones market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The Biosimilar Hormones Global Market Report 2022 covers biosimilar hormones market drivers, biosimilar hormones market trends, biosimilar hormones market segments, biosimilar hormones market growth rate, biosimilar hormones market major players, and biosimilar hormones market size. The global biosimilar hormones market size is expected to grow from $1. The biosimilar hormones market share is expected to reach $6. id=3432&type=smpBiosimilar Hormones Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.

Pooja tbrc 2023-07-13

The Biosimilar Interleukins Global Market Report 2023, provides comprehensive information on the biosimilar interleukins market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. id=3433&type=smp The biosimilar interleukins market is segmented: 1) By Type: IL-17, IL-23, IL-1, IL-5, IL-6 2) By Application: Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease (IBD), Other Applications 3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Clinics, Research Institutes North America was the largest region in the biosimilar interleukins market in 2022. Africa Biosimilar Interleukins Market 27. Key Mergers And Acquisitions In The Biosimilar Interleukins Market 29. Appendix Read Related Reports https://www.

Edward E . Breen 2022-07-19

According to the recent report by IMARC Group, entitled “Biosimilar Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2022-2027”, the biosimilars market reached a value of US$ 13. A biological drug must be proved similar in terms of safety, quality, and efficacy to be labeled as a biosimilar. Request for a PDF sample of this report: https://www. About Us:IMARC Group is a leading market research company that offers management strategy and market research worldwide. Contact Us:IMARC Group30 N Gould St Ste RSheridan, WY 82801 USA - WyomingEmail: Sales@imarcgroup.

Shashwat 2023-11-08

In 2022, the dominance region is North region in US Biosimilar market. Click here to Download a Custom ReportCompetition Scenario in US Biosimilar MarketThe US biosimilar market has witnessed an evolving competitive landscape, with several key players competing for market share. The competition in the US biosimilar market is characterized by a balance between established pharmaceutical giants and emerging biotech companies. What is the Expected Future Outlook for the Overall US Biosimilar Market? The US biosimilar market is likely to experience significant growth in the coming years, driven by several factors.

Aishwarya Bhasme 2023-08-02

Biswadeep 2022-05-23

Ruchita 2022-01-28

Santhosh 2022-05-20

Humira Market Size, Share, Future Industry Projections & Forecast Report 2020-2025

Joshna Cristila 2020-04-18

The statistical surveying report on the global Humira Market has been presented by using professional or expert knowledge through standard and modified research approaches and forecasts.

The yearly forecast and predication for the years 2020 to 2025 have been enclosed by the report along with comprehensive analysis for all market segments and regions.

The statistical data derived from authentic resources and assisted by industry experts.

It likewise assesses the market by evaluating market elements, including drivers, restraints, opportunities, threats, challenges, growth prospects, and other market elements.

Ramya 2022-05-25

Ganesh Shinde 2023-02-03

saikiran TBRC 2024-03-02

Pooja tbrc 2023-07-13

Aafiya.Khanam 2021-11-17

Edward E . Breen 2022-07-19

kashish Singh 2023-04-12

Shashwat 2023-11-08

Devanand Patil 2021-10-13

Herceptin Biosimilar Market: IntroductionTrastuzumab, sold under the brand Herceptin, is a monoclonal antibody used to treat patients suffering from HER2+ve breast cancer and gastric cancers.

It is primarily administered intravenously in cancer patients.

Increase in incidence and prevalence of gastric & breast cancer among people, especially women, is a key factor boosting the growth of the global Herceptin biosimilar market.